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Abstract
Introduction
Current studies of depression among people living with HIV focus on describing its point
prevalence. Given the fluctuating nature of depression and its profound impacts on clinical
and quality-of-life outcomes, this study aimed to examine the prevalence, recurrence and
incidence of current depressive symptoms and its underlying catalysts longitudinally and
systematically among these individuals.
Methods
We conducted a prospective cohort study between October 1, 2007 and December 31,
2012 using longitudinal linked data sources. Current depressive symptoms was identified
using the Centre for Epidemiologic Studies Depression Scale or the Kessler Psychological
Distress Scale, first at baseline and again during follow-up interviews. Multivariable regres-
sions were used to characterize the three outcomes.
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Results
Of the 3,816 HIV-positive participants, the point prevalence of depressive symptoms was
estimated at 28%. Of the 957 participants who were identified with depressive symptoms at
baseline and who had at least two years of follow-up, 43% had a recurrent episode. The
cumulative incidence among 1,745 previously depressive symptoms free participants (at or
prior to baseline) was 14%. During the five-year follow-up, our multivariable models showed
that participants with greater risk of recurrent cases were more likely to feel worried about
their housing situation. Participants at risk of developing incident cases were also likely to
be younger, gay or bisexual, and unable to afford housing-related expenses.
Conclusions
Depressive symptoms are prevalent and likely to recur among people living with HIV. Our
results support the direction of Ontario’s HIV/AIDS Strategy to 2026, which addresses med-
ical concerns associated with HIV (such as depression) and the social drivers of health in
order to enhance the overall well-being of people living with or at risk of HIV. Our findings
reinforce the importance of providing effective mental health care and demonstrate the
need for long-term support and routine management of depression, particularly for individu-
als at high risk.
Introduction
Depression affects up to half of people living with HIV, a prevalence that is two to four times
higher than that found in the general population [1]. Over 50% of people living with HIV and
depression do not receive treatment for their depression [2–9], and this failure to treat contrib-
utes to significant negative clinical and quality-of-life outcomes [10–14].
Growing evidence supports a bi-directional relationship betweenHIV and depression
involving a number of biological, psychosocial and social factors [1,14–16]. The persistent viral
presence in the central nervous systemmay release toxic viral proteins that induce depression-
like symptoms [17,18]; people living with HIVmay possess a negative self-image or experience
stigma [1,15,19–21]; and people living with HIV are more likely to strugglewith stressors such
as financial insecurity and unstable housing [22–25]. Recent reviews also suggest that people
who suffer from severe mental illnesses (including depression) and/or co-occurring substance
use disorder are more likely to engage in risky sexual behaviour, thereby elevating their risk of
HIV acquisition [26–34].
To date, most studies about the prevalence of depression among people living with HIV
have used cross-sectional designs [1,15]. Six studies have documented the incidence [35–38]
and persistence (or recurrence) [39,40] of depression over time among people living with HIV.
In Canada, information describing the epidemiology of depression among people living with
HIV is scarce. In Canada, information describing the epidemiology of depression among peo-
ple living with HIV is scarce. There have been two small convenience sample studies describing
the prevalence of depression among people living with HIV. Williams et al. (2005), employing
a small convenience sample of 297 individuals, described the prevalence of depressive symp-
toms at 54% among people living with HIV based on a self-report screening instrument [41].
Logie, James, Tharao, and Loutfy (2013), employing a sample of 173 Africa, Caribbean, and
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Black women, described the prevalence of depressive symptoms as 64% [42]. Thus, the epide-
miology of this condition is not yet well documented in Canada.
Given the fluctuating nature of depression over the life span and its profound impacts on
clinical and quality-of-life outcomes, our study aimed to examine the prevalence, recurrence,
and incidence of current depressive symptoms longitudinally and systematically among people
living with HIV. We also characterized these three outcomes by HIV-positive participants’
socio-demographic characteristics, housing and neighbourhoodconditions, substance-use
behaviours and health status over a five-year follow-up period.Understanding change in the
burden of depressive symptoms and the underlying catalysts of the condition from a longitudi-
nal perspectivewould be important to program planners, policy-makers, and health care pro-
viders when planning and implementing effectivemental-health programs and interventions
for people living with HIV.
Materials and Methods
Study Design and Data Sources
We conducted a prospective cohort study betweenOctober 1, 2007 and December 31, 2012 by
linking unique encoded identifiers from the Ontario HIV Treatment Network Cohort Study
(OCS)with national and provincial administrative health databases held at the Institute for Clini-
cal Evaluative Sciences (ICES). Details about the linked data source have been provided in a
recent study [9]. We have obtained ethics approvals for the use of the linked data from the Uni-
versity of Toronto, the institutional review board at Sunnybrook Health SciencesCentre, and
participatingHIV clinics across Ontario (i.e., the Institutional ReviewBoard at Sunnybrook
Health SciencesCentre, Ottawa Health ScienceNetwork Research Ethics Board, The University
of Western Ontario Research Ethics Board for Health SciencesResearch involving Human Sub-
jects, St. Michael's Hospital Research Ethics Board, the Research Ethics Board of Health Sciences
North, Sunnybrook Health SciencesCentre Research Ethics Board, University Health Network
Research Ethics Board, andWindsor RegionalHospital Research Ethics Board).
The OCS is a multi-site HIV cohort, described in detail in a previous publication [43]. HIV-
positive participants who received care were recruited fromHIV specialty care clinics in Ontario.
Clinical nurses and assistants interviewed the HIV-positive participants during regular clinical
appointments [43]. The OCS data source contains participants’ medical records from chart
abstractions, HIV viral load/HIV antigen test records provided by Public Health Ontario Labora-
tories, socio-demographics, and psychosocial and behavioural data [43]. The frequency of fol-
low-up for each HIV-positive participant depended on the frequency of his/her clinical
appointments. Most HIV-positive participants completed follow-up interviews annually, while
3.5% of the sample completed interviewsmore than once a year. We defined baseline as the time
when the HIV-positive participants completed their first interview. The median number of inter-
views completed during our study period by each participant was three (interquartile range: 2–4).
We used four administrative health databases to obtain additional information about partic-
ipants’ past diagnoses of depression, other psychiatric disorders and death records. In Canada,
according to the Canada Health Act, the publicly funded universal health care system covers
medical and hospital services provided by physicians for insured residents of Canada, and
these databases capture information for all publicly-funded services.
1. The Ontario Health Insurance Plan (OHIP) database contains billing records for all insured
services claimed by physicians and other health professionals.
2. The Canadian Institute for Health Information Discharge Abstracts Database (DAD) contains
abstracts of all discharges from acute, chronic and rehabilitation inpatient facilities [44].
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3. The National Ambulatory Care Reporting System (NACRS) captures all emergency depart-
ment visits [45].
4. The Registered Persons Database (RPDB) captures death records of everyone insured under
OHIP.
Study Participants
HIV-positive participants were included in the analysis if they were 16 years or older, had a
valid OHIP number to link to administrative databases, had completed their baseline interview
betweenOctober 1, 2007 and December 31, 2012, and had one measure of their current level of
depressive symptoms available.
Determining Depressive Symptoms
Current depressive symptoms (i.e., within the past month) was identified using two short screen-
ing instruments. Due to resource-constraints in several HIV clinics, 61% of HIV-positive partici-
pants were administered the 10-item Kessler Psychological Distress Scale (K10) and the rest were
administered the 20-item Centre for Epidemiologic Depression Scale (CES-D20). Diagnostic
accuracy and reliability of the two screening instruments were verified against Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for
a major depression diagnosis from a recent study conducted in a sample of HIV-positive partici-
pants [46]. To identify current depressive symptoms, we used a cut-point of 22 (sensitivity: 0.97;
specificity:0.81) for K10 [46] and a cut-point of 23 (sensitivity: 1.0; specificity:0.87) for CES-D20
[46]. The CES-D20 and K10 demonstrate good inter-rater agreement (Cohen’s Kappa Statis-
tic = 0.79) when compared with the DSM-IV-TR criteria for a diagnosis of major depression
[46]. Current depressive symptoms was measured at baseline and at each follow-up. CES-D20
and K10 have been adopted to identify depressive symptoms in general population [47–49], HIV-
positive individuals [50,51], and individuals with chronic illness [52].
A history of depression was defined as having an International Statistical Classification of
Diseases 9th revision (ICD-9) or 10th revision (ICD-10) diagnostic code (Table 1) in the OHIP,
DAD or NACRS databases from the earliest available record until one year prior to baseline
[44,45]. We allowed one year as a washout period to avoid any overlap between current depres-
sive symptoms and past diagnosis of depression [53].
A prevalent case was defined as a participant with current depressive symptoms at baseline.
An incident case was defined as a depressive symptoms-free participant (at or prior to baseline)
having their first episode of depressive symptoms during the five-year follow-up period. A first
recurrent case was defined as a participant who was identifiedwith current depressive symp-
toms at baseline, re-identifiedwith current depressive symptoms beyond two years after base-
line, and for whom there was at least one eight-week depression-free periods between baseline
and the date of recurrent depressive symptoms (Fig 1) [54,55]. To identify a depression-free
period,we looked for depression-related diagnostic codes in the OHIP, DAD, or NACRS data-
bases between interviewdates.
Mental Disorder Co-Morbidities
We measured other mental disorder co-morbidities (except for depression-related conditions)
according to the sixteen ICD-9 disease sub-categories [56]. This diagnostic information was
obtained from the OHIP database from the earliest available record [56].
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Individual and Contextual Explanatory Variables
We selected individual explanatory variables and contextual explanatory variables (housing
status, participants’ perception of their neighbourhood)known to be associatedwith depressive
symptoms. More details about these explanatory variables are provided in S1 Appendix.
Statistical Analysis
All statistical tests were two-sidedwith statistical significance defined as a p-value<0.05. Anal-
yses were performed using STATA MP v. 13.1 [57]. Our analyses were conducted at the ICES.
Table 1. International Statistical Classification of Diseases 9th (ICD-9) or 10th (ICD-10) revision Diag-
nostic Codes for Identifying History of Depression.
ICD-9 diagnostic codes ICD-10 diagnostic codes
296.2 Major depressive disorder single
episode
F32.0 Mild depressive episode
309.0 Adjustment disorder with depressed
mood
F33.0 Recurrent depressive disorder, current episode mild
296.3 Major depressive affective disorder,
recurrent episode
F32.1 Moderate depressive episode
309.1 prolonged depressive reaction F33.1 Recurrent depressive disorder, current episode
moderate
311 Depressive disorder, not elsewhere
classified
F32.2 Severe depressive episode without psychotic
symptoms
300.4 Dysthymic disorder F32.3 Severe depressive episode with psychotic symptoms
F33.2 Recurrent depressive disorder, current episode
severe without psychotic symptoms
F33.3 Recurrent depressive disorder, current episode
severe with psychotic symptoms
F33.4 Recurrent depressive disorder, currently in remission
F33.8 Other recurrent depressive disorders
F33.9 Recurrent depressive disorder, unspecified
F32.8 Other depressive episodes
F32.9 Other depressive episodes
F38.0 Other single mood disorders
F38.1 Other recurrent mood disorders
F38.8 Other specified mood disorders
doi:10.1371/journal.pone.0165816.t001
Fig 1. Illustration for Definition of Recurrent Depressive Symptoms.
doi:10.1371/journal.pone.0165816.g001
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We describedoverall and explanatory variable-specificprevalence (point and period), recur-
rence, and incidence for current depressive symptoms. Point prevalence was calculated as the
number of cases with current depressive symptoms at baseline. The denominator in point prev-
alence calculations includedHIV-positive participants who had completed their baseline inter-
view betweenOctober 1, 2007 and December 31, 2012, and who had one measure for
identifying current depressive symptoms (Fig 2). The period prevalence rate was calculated as
the number of cases with depressive symptoms per 100 person-years during the five-year fol-
low-up period. The denominator in period prevalence rate calculations was person-years of
HIV-positive participants included in the point prevalence calculation (Fig 2). The recurrence
rate was calculated as the number of first recurrent cases with depressive symptoms per 100
person-years during the five-year follow-up period among participants identifiedwith current
depressive symptoms at baseline (Fig 2). The denominator in recurrence calculations were per-
son-years of HIV-positive participants who had completed their baseline interviewbetween
October 1, 2007 and December 31, 2010, and who had identifiedwith current depressive symp-
toms at baseline (Fig 2). We allowed at least two years to observe recurrent cases until the end
of our study period (Fig 2). The incidence rate was calculated as the number of incident cases
with depressive symptoms per 100 person-years during the five-year follow-up period among
participants who were depressive symptom-free at baseline and previously (Fig 2). The denom-
inator in incidence calculations were person-years of HIV-positive participants who had com-
pleted their baseline interviewbetweenOctober 1, 2007 and December 31, 2011, and who were
depressive symptom-free at or prior to the baseline (Fig 2). We allowed at least one year to
observe incident cases until the end of our study period (Fig 2). We usedWald test for
Fig 2. Participant Flow Chart for Development of Prevalence, Recurrence, and Incidence Cohorts.
doi:10.1371/journal.pone.0165816.g002
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bivariable point prevalence comparison, and a Logrank test for bivariable period prevalence,
incidence, and recurrence rates comparison.
We also used frequency and proportion to determine how many participants had mental
disorder co-morbidities in addition to current depressive symptoms at baseline.We used Chi-
square or Fisher exact test for bivariable proportion comparison by the participants’ current
status of depressive symptoms at baseline.
Several explanatory multivariable models were constructed to examine associations between
potential explanatory variables and the point prevalence, recurrence and incidence of current
depressive symptoms. Explanatory variables entered into and kept in the explanatory multivar-
iate models were based on evidence from prior studies [38,58–61].When an explanatory vari-
able did not have a priori evidence, we used a backward selectionmethod [62–64]. This was
done by calculating the p value thresholds of the Akaike information criteria (AICs) or Bayes-
ian information criteria (BICs) for two nested models. A p-value threshold of either<0.00408
or<0.2 would provide the minimal BIC/AIC when deciding if an explanatory variable without
a priori literature should be kept in the model. Because there is a wide gap between these two
p-value thresholds, we considered two more p-value thresholds: p< 0.15 and p< 0.10. At each
step of the backward selection procedure, the p value threshold was used to determine if it was
appropriate to keep the explanatory variable. This process was done for all of the p value
thresholds, separately. The final set of explanatory variables was selected based on the lowest
AICs and BICs of the full model (include all explanatory variables) and the final models
according to the four p-value criteria [62–64]. To further examine uncertainty in the model
building procedure, we generated 1,000 bootstrapped samples from our original dataset to
examine the probability for each explanatory variable (those without prior evidence) to be
retained in the final model.
As we discussed in the methods section, K10 was administered in several HIV clinics with
resources constraints, it is possible that the characteristics of participants differed between clin-
ics. In each of our final explanatory models, we controlled for differences between the CES-D20
and K10 as well as the residual difference of participants’ characteristics by the clinic type.
We first constructedmodifiedPoisson regression models with robust error variance to
examine factors associated with point prevalence [65].
Second, we constructedCox proportional hazard regressionmodels to examine factors asso-
ciated with first recurrent depressive symptoms during the five-year follow-up period among
HIV-positive participants with current depressive symptoms. In the final model, we also con-
trolled for the use of antidepressants as identified in the participants’ medical records from
clinical abstractions. The definition of antidepressants was based on the first line of antidepres-
sants for managing depression in adults recommended by the Canadian Network for Mood
and Anxiety Treatments (CANMAT) Clinical guidelines [66].
Third, we constructedCox proportional hazard regression models to examine factors asso-
ciated with the incidence of depressive symptoms among HIV-positive participants who had
no history of depression at or prior to baseline.
For each Cox model, we tested proportionality assumptions by Schoenfeld residuals against
time for each explanatory variable and interactions with linear time and natural log of time.
When the variable did not meet the proportionality assumptions, our final multivariable Cox
proportional hazard model was stratified by this variable that did not meet the assumptions.
Adjusted relative risk (aRR) and 95% confidence intervals (CIs) were reported for the asso-
ciation between each explanatory variable and point prevalence outcome. Adjusted hazard
ratio (aHR) were reported for the association between each explanatory variable and incidence
and recurrence outcomes.
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Results
We included 3,816 HIV-positive participants at baseline in our final analysis. The median age
of participants was 46 years (Interquartile range: 39–52), and 17% were female. Table 2 con-
tains the baseline characteristics of our sample overall and by instrument type. Briefly, 66%
were gay or bisexual, 45% had annual household incomes below $40K CAD, 41% were current
smokers and 39% had a history of depression. We noted a number of difference in participants
by instrument types. For example, participants who completed the K10 (as opposed to the
CES-D20) were more likely to be female (57 vs. 43%, p-value = 0.01633), more likely to have
difficulty in affording housing-related expenses (53 vs. 47%, p<0.0001), more likely to have a
sense of belonging to their neighbourhoods (57 vs. 43%, p-value<0.0001), and more likely to
have control over their housing situation (58 vs. 42%, p-value<0.0001).We therefore included
a variable to control for differences between instrument types in our final models.
Prevalence of Current Depressive Symptoms
We included 3,816 HIV-positive participants in our prevalence estimation of current depres-
sive symptoms (Fig 2 & Table 3). When we compared the characteristics of the participants
included in the prevalence sub-cohort to the remainder of the cohort, we found that partici-
pants were slightly younger (mean age: 53 v. 56 years; p-value:<0.0001) and more likely to be
female (16.8 v. 10.5%; p-value:<0.0001).
Our point prevalence was 28% (95% CI: 27–29%) at baseline. By the end of the follow-up
period, our period prevalence rate was 4.9 per 100 person-years (95% CI: 4.8–5.1). Consistent
results were observedbetween explanatory variables and both prevalence outcomes (Table 3).
For example, more young participants were found to be depressed than participants who were
50 years or older. More women than men were found to be depressed. A higher point preva-
lence and period prevalence rate of depressive symptoms was found among participants who
were: Indigenous, unemployed, disabled, or who had lower educational attainment or low
incomes. Higher rates were also found among those who had a history of depression, a history
of harmful behaviour, a severe HIV condition or other co-morbidity, and/or poorer housing or
neighbourhoodconditions.
Recurrence
We included 957 HIV-positive participants with current depressive symptoms identified at base-
line and had at least two-year follow-up data in our recurrence estimation (Fig 2 & Table 3).
When we compared the characteristics of participants included in the recurrence sub-cohort to
the remainder of the cohort, we found that participants were slightly younger (mean age: 52 v. 55
years; p-value:<0.0001) and more likely to be female (20.9 v. 13.5%; p-value:<0.0001).
By the end of the follow-up period, 43% of participants with current depressive symptoms
at baseline had a recurrent episode. The first recurrence rate of current depressive symptoms
was 11.9 per 100 person-years (95% CI: 10.8–13.2). The rate peakedwith participants who
were 50 or older (15.3 per 100 person-years; 95% CI: 13.1–17.9). A higher recurrence rate was
found among participants who were European decent or Indigenous, or who were employed or
disabled, students or retired, and among those who lived in poorer housing, had supressed
recent viral loads, and/or had completed the K10.
Incidence
We included 1,745 HIV-positive participants whowere depressive symptoms-free at or prior to
baseline and who had at least one year of follow-up data for our incidence estimation (Fig 2 &
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Table 2. Baseline Characteristics of the Samples (N = 3816).
Characteristics Total By Instrument Types a
K10 CES-D20 p-value
(N = 3,816) (N = 2346) (N = 1470)
N % N % N %
Demographics
Age 0.004090
16–29 years 273 (7%) 180 (66%) 93 (34%)
30–39 years 651 (17%) 426 (65%) 225 (35%)
40–49 years 1492 (39%) 929 (62%) 563 (38%)
 50 years 1244 (33%) 726 (58%) 518 (42%)
Gender 0.01633
Female 646 (17%) 366 (57%) 280 (43%)
Male 3169 (83%) 1979 (62%) 1190 (38%)
Sexual orientation 0.1242
Gay, lesbian, or bisexual 2,532 (66%) 1585 (63%) 947 (37%)
Heterosexual 1262 (33%) 747 (59%) 515 (41%)
Marital status 0.5413
Married / living with partners 1,517 (40%) 940 (62%) 577 (38%)
Single, separated/divorced, or widowed 2287 (60%) 1397 (61%) 890 (39%)
Ethnic identity < 0.0001
European descent 3,217 (84%) 1992 (62%) 1225 (38%)
First Nation, Metis, or Inuit 383 (10%) 295 (77%) 88 (23%)
African, Caribbean, Asian, or Latin American 215 (6%) 59 (27%) 156 (73%)
Immigration status < 0.0001
Canadian immigrant 1,110 (29%) 510 (46%) 600 (54%)
Canadian born 2697 (71%) 1835 (68%) 862 (32%)
Socio-economic Status
Current employment status 0.2127
Employed 1799 (47%) 1079 (61%) 702 (39%)
Unemployed 363 (10%) 219 (60%) 144 (40%)
Student/Retired 329 (9%) 204 (62%) 125 (38%)
Recipient of Ontario Disability Support Program 1,312 (34%) 814 (62%) 498 (38%)
Educational attainment
Completed high school or less 1,245 (33%) 774 (62%) 471 (38%) 0.5418
More than high shcool 2571 (67%) 1572 (61%) 999 (39%)
Annual household income (CAD) before withholding taxes/benefits < 0.0001
< $20,000 995 (26%) 599 (60%) 396 (40%)
$20,000 to $39,999 709 (19%) 418 (59%) 291 (41%)
$40,000 to $49,999 483 (13%) 298 (62%) 185 (38%)
 $50,000 1252 (33%) 752 (60%) 500 (40%)
Housing and Neighbourhood Conditions
Difficulty in affording housing-related expenses b < 0.0001
Yes 889 (23%) 469 (53%) 420 (47%)
No 2552 (67%) 1509 (59%) 1043 (41%)
Worry about being evicted c < 0.0001
Yes 592 (16%) 309 (52%) 283 (48%)
No 2863 (75%) 1677 (59%) 1186 (41%)
Having control over their housing situation c <0.0001
Yes 2881 (76%) 1676 (58%) 1205 (42%)
No 575 (15%) 310 (54%) 265 (46%)
Sense of belonging to neighbourhood c < 0.0001
Yes 2513 (66%) 1435 (57%) 1078 (43%)
(Continued)
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Table 2. (Continued)
Characteristics Total By Instrument Types a
K10 CES-D20 p-value
(N = 3,816) (N = 2346) (N = 1470)
N % N % N %
No 943 (25%) 551 (58%) 392 (42%)
Perceive good location of their home c < 0.0001
Yes 2901 (76%) 1672 (58%) 1229 (42%)
No 555 (15%) 310 (54%) 265 (46%)
Harmful Behaviours
Recreational drug use in past 6 months < 0.0001
Yes 807 (21%) 561 (70%) 246 (30%)
No 3006 (79%) 1784 (59%) 1222 (41%)
Prior diagnosis of alcohol abuse d 0.02396
Yes 435 (11%) 289 (66%) 146 (34%)
No 3381 (89%) 2057 (61%) 1324 (39%)
Current smoker < 0.0001
Yes 1,567 (41%) 1056 (67%) 511 (33%)
No 2237 (59%) 1278 (57%) 959 (43%)
Health Status
Current depressive symptoms < 0.0001
Yes 1070 (28%) 742 (69%) 328 (31%)
No
History of depression e < 0.0001
Yes 1,504 (39%) 988 (66%) 516 (34%)
No 2312 (61%) 1358 (59%) 954 (41%)
Physical component of SF-12, median (25th to 75th percentile) 52 (42–57) 52 (41–57) 52 (43–56) 0.3526
Charlson co-morbidity index  1 0.3245
Yes 966 (25%) 581 (60%) 385 (40%)
No 2850 (75%) 1765 (62%) 1085 (38%)
Non-suppressed recent viral loads (> 50 μL) (in past 6 months) 0.2999
Yes 1080 (28%) 678 (63%) 402 (37%)
No 2736 (72%) 1668 (61%) 1068 (39%)
Years since HIV diagnosis, median (25th to 75th percentile) 11 (5–17) 11 (5–17) 11 (5–17) 0.3020
a There are two instruments for identifying current depressive symptoms administered by clinic nurses and assistant during the participant’s regular clinical
appointments. Due to constraints on human resources and time in several HIV clinics, 61% of HIV-positive participants were administered the 10-item
Kessler Psychological Distress Scale (K10) and 39% were administrated the 20-item Centre for Epidemiologic Studies Depression Scale (CES-D20). Full
details of the cohort can be found on the study website: http://www.ohtncohortstudy.ca/
b Difficulty in affording house-related expenses was defined as a participant’s self-reported “Very difficult” or “Fairly difficult” for the following question:
“Considering your household income, how difficult is it for you to meet your monthly housing-related costs?(Housing costs include rent/mortgage, property
taxes and utilities only).”
c A 5-point Likert scale (strongly agree to strongly disagree) was used. We dichotomized their response into “yes” (strongly agree/agree) and “no” (neutral/
disagree/strongly disagree).
d Addiction to alcohol was defined as a diagnostic code of alcohol dependence/abuse in OHIP (ICD-9: 303) or in main diagnosis of DAD and NACRS (ICD-
9-CM: 303; ICD-10-CA: F10), from the earliest available records to a day before the baseline.
e History of depression was defined as having a past depression-related diagnosis in OHIP records (OHIP ICD-9: 296 and 311), from the earliest available
records to a year before baseline.
doi:10.1371/journal.pone.0165816.t002
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Table 3. Point Prevalence (PP), Period Prevalence Rate (PPR), Recurrence Rate (RR) Incidence Rate (IR) of Current Depressive Symptoms by
Explanatory Variables among HIV-positive Participants.
Prevalence Recurrence Rate Incidence Rate
Point Prevalence Period Prevalence Rate
(N = 3816) (N = 3816) (N = 957) (N = 1,745)
PP 95% CI p-value PPR 95% CI p-value RR 95% CI p-value IR 95% CI p-value
Overall 28% (27,
29)
13.5 (12.8,
14.2)
11.9 (10.8,
13.2)
4.5 (3.9, 5.1)
Demographics
Age <0.0001 <0.0001 0.05319 <0.0001
16–29 years 30% (25,
36)
19.3 (16.1,
23.2)
7.4 (4.5, 12.3) 7.2 (4.7,
10.9)
30–39 years 34% (30,
37)
17.4 (15.6,
19.6)
8.0 (6.1, 10.4) 6.3 (4.7, 8.4)
40–49 years 30% (27,
32)
14.6 (13.5,
15.8)
12.1 (10.4,
14.1)
4.4 (3.5, 5.5)
 50 years 22% (20,
24)
10.0 (9.1, 11.0) 15.3 (13.1,
17.9)
3.7 (3.0, 4.6)
Gender <0.0001 <0.0001 0.5826 0.003427
Female 37% (33,
40)
18.8 (16.8,
20.9)
11.3 (9.1, 14.1) 6.1 (4.6, 8.1)
Male 26% (25,
28)
12.6 (11.9,
13.3)
12.1 (10.8,
13.4)
4.2 (3.6, 4.8)
Sexual orientation <0.0001 <0.0001 0.8231 0.1463
Gay, lesbian, or bisexual 26% (24,
27)
12.4 (11.6,
13.2)
12.4 (11.0,
14.0)
4.3 (3.7, 5.1)
Heterosexual 33% (30,
36)
16.0 (14.7,
17.4)
11.2 (9.5, 13.2) 4.8 (3.9, 6.0)
Marital status <0.0001 <0.0001 0.06293 0.000348
Married / living with partners 22% (20,
24)
10.5 (9.6, 11.4) 11.0 (9.3, 13.2) 3.4 (2.8, 4.3)
Single, separated/divorced, or windowed 32% (30,
34)
15.6 (14.7,
16.6)
12.3 (11.0,
13.9)
5.4 (4.6, 6.3)
Ethnic identity <0.0001 0.03283 0.02803
European descent 27% (26,
29)
0.000844 13.0 (12.3,
13.8)
12.3 (11.0,
13.6)
4.3 (3.8, 4.9)
First Nation, Metis, or Inuit 37% (32,
42)
18.7 (16.2,
21.5)
11.8 (9.0, 15.4) 6.4 (4.4, 9.3)
African, Caribbean, Asian, or Latin American 27% (21,
33)
11.8 (9.3, 14.9) 7.5 (4.4, 12.7) 3.7 (1.7, 8.3)
Canadian immigration status 0.8150 0.1627 0.2280 0.7249
Yes 27% (25,
30)
13.1 (11.9,
14.5)
12.3 (10.4,
13.2)
4.7 (3.8, 5.8)
No 28% (27,
30)
14.1 (13.3,
15.0)
11.7 (10.3,
14.8)
4.4 (3.7, 5.1)
Socio-economic Status
Current employment status <0.0001 <0.0001 0.008041 <0.0001
Employed 16% (14,
17)
7.9 (7.2, 8.7) 11.0 (9.1, 13.2) 3.2 (2.7, 3.9)
Unemployed 37% (32,
42)
18.5 (15.9,
21.6)
6.6 (4.3, 10.0) 4.4 (2.7, 7.4)
Student/Retired 16% (12,
19)
7.5 (6.1, 9.2) 14.8 (9.9, 22.1) 2.9 (1.9, 4.6)
Recipient of Ontario Disability Support Program 45% (43,
48)
23.5 (21.9,
25.2)
13.0 (11.5,
14.7)
8.6 (7.1,
10.4)
Educational attainment <0.0001 0.9028 0.000516
Completed high school or less 36% (33,
39)
<0.0001 17.5 (16.1,
18.9)
11.1 (9.4, 13.0) 6.0 (4.8, 7.4)
(Continued)
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Table 3. (Continued)
Prevalence Recurrence Rate Incidence Rate
Point Prevalence Period Prevalence Rate
(N = 3816) (N = 3816) (N = 957) (N = 1,745)
PP 95% CI p-value PPR 95% CI p-value RR 95% CI p-value IR 95% CI p-value
More than high school 24% (23,
26)
11.7 (11.0,
12.5)
12.5 (11.1,
14.2)
3.9 (3.3, 4.6)
Annual household income (CAD) before withholding
taxes/benefits
<0.0001 <0.0001 0.1647 <0.0001
< $20,000 42% (39,
45)
22.0 (20.2,
23.8)
12.5 (10.8,
14.5)
8.3 (6.7,
10.4)
$20,000 to $39,999 32% (28,
35)
15.5 (13.9,
17.4)
13.4 (11.0,
16.4)
4.7 (3.5, 6.4)
$40,000 to $49,999 19% (16,
23)
9.9 (8.4, 11.6) 10.7 (7.7, 14.9) 4.0 (2.8, 5.7)
 $50,000 16% (14,
18)
7.6 (6.8, 8.5) 10.8 (8.5, 13.6) 2.8 (2.1, 3.5)
Housing and Neighbourhood Conditions
Difficulty in affording housing-related expenses a <0.0001 <0.0001 0.002721 <0.0001
Yes 45% (41,
48)
26.2 (24.0,
28.1)
14.5 (12.5,
16.9)
9.7 (7.8,
12.0)
No 21% (20,
23)
10.5 (9.8, 11.3) 13.1 (11.5,
14.8)
3.4 (2.9, 4.0)
Worry about being force out from their home b <0.0001 <0.0001 0.000306 <0.0001
Yes 48% (44,
52)
28.2 (25.6,
31.2)
15.9 (13.4,
18.9)
11.1 (8.6,
14.3)
No 23% (22,
25)
11.5 (10.8,
12.2)
12.8 (11.4,
14.4)
3.7 (3.2, 4.3)
Having control over their housing situation b <0.0001 <0.0001 0.000134 <0.0001
Yes 23% (22,
25)
11.6 (10.9,
12.3)
12.9 (11.5,
14.4)
4.0 (3.5, 4.7)
No 48% (44,
52)
28.6 (25.8,
31.6)
16.0 (13.4,
19.1)
7.0 (5.4, 9.2)
Sense of belonging to neighbourhood b <0.0001 <0.0001 0.001541 <0.0001
Yes 22% (21,
24)
11.0 (10.3,
11.8)
13.3 (11.8,
15.1)
3.8 (3.2, 4.4)
No 40% (37,
43)
23.4 (21.4,
25.4)
14.2 (12.2,
16.6)
6.9 (5.5, 8.5)
Perceive good location of their home b <0.0001 <0.0001 0.004199 <0.0001
Yes 23% (22,
25)
11.8 (11.1,
12.5)
13.3 (11.9,
14.9)
4.0 (3.5, 4.6)
No 48% (44,
52)
27.8 (25.0,
30.8)
14.9 (12.4,
17.9)
7.2 (5.5, 9.4)
Harmful Behaviours
Recreational drug use in past 6 months <0.0001 <0.0001 0.5917 0.000258
Yes 39% (36,
42)
21.3 (19.4,
23.4)
11.1 (9.1, 13.5) 6.4 (4.8, 8.4)
No 25% (24,
27)
11.9 (11.2,
12.6)
12.3 (11.0,
13.7)
4.1 (3.6, 4.8)
Prior diagnosis of alcohol abuse c <0.0001 <0.0001 0.5977 0.2327
Yes 44% (39,
49)
22.3 (19.7,
25.3)
11.7 (9.3, 14.7) 5.7 (3.5, 9.2)
No 26% (24,
27)
12.5 (11.9,
13.2)
12.0 (10.8,
13.3)
4.4 (3.8, 5.0)
Current smoker <0.0001 <0.0001 0.6678 <0.0001
Yes 37% (34,
39)
18.7 (17.5,
20.1)
12.1 (10.6,
13.8)
5.7 (4.7, 7.0)
No 22% (20,
24)
10.4 (9.7, 11.2) 11.8 (10.2,
13.5)
3.9 (3.3, 4.6)
(Continued)
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Table 3). When we compared the characteristics of participants included in the incidence sub-
cohort to the remainder of the cohort, we found that participants were slightly younger (mean age:
54 v. 55 years; p-value: 0.0019) and more likely to be female (16.1 v. 14.2%; p-value: 0.059).
Among the 1,745 depressive symptoms-free participants, the cumulative incidence of cur-
rent depressive symptoms was 14% by the end of the follow-up period (Table 3). The incidence
rate of current depressive symptoms was 4.5 per 100 person-years (95% CI: 3.9–5.1) and
peaked at 16–29 years (7.2 per 100 person-years; 95% CI: 4.7–10.9).Women had a higher inci-
dence rate (6.1 vs. 4.2 per 100 person-years) than men. A higher incidence rate was found
among participants who were disabled, recreational drug users, current smokers, separated/
Table 3. (Continued)
Prevalence Recurrence Rate Incidence Rate
Point Prevalence Period Prevalence Rate
(N = 3816) (N = 3816) (N = 957) (N = 1,745)
PP 95% CI p-value PPR 95% CI p-value RR 95% CI p-value IR 95% CI p-value
Health Status
History of depression d <0.0001 <0.0001 0.5824
Yes 40% (38,
43)
20.1 (18.8,
21.5)
12.5 (11.0,
14.1)
— —
No 20% (18,
22)
9.8 (9.1, 10.6) 11.2 (9.6, 13.1) — —
Charlson co-morbidity index  1 <0.0001 <0.0001 0.4327 0.7021
Yes 35% (32,
38)
16.5 (15.0,
18.1)
12.1 (10.1,
14.4)
4.3 (3.3, 5.7)
No 26% (24,
27)
12.6 (11.8,
13.3)
11.9 (10.6,
13.4)
4.5 (3.9, 5.2)
Non-suppressed recent viral loads (> 50 μL)(in past 6
months)
<0.0001 <0.0001 0.03633 <0.0001
Yes 35% (32,
38)
19.3 (17.6,
21.1)
7.4 (5.8, 9.4) 5.5 (4.2, 7.2)
No 25% (24,
27)
11.9 (11.2,
12.7)
13.6 (12.2,
15.1)
4.2 (3.7, 4.9)
Instrument Type e <0.0001 <0.0001 <0.0001 0.001045
CES-D20 22% (20,
24)
10.0 (9.1, 11.0) 9.8 (8.0, 11.9) 3.6 (2.9, 4.5)
K10 32% (30,
34)
15.9 (15.0,
16.9)
12.9 (11.5,
14.4)
5.1 (4.4, 6.0)
CI = confidence intervals, PP = point prevalence, expressed in percentage, PPR = period prevalence rate per 100 person-years, RR = recurrent rate per
100 person-years, IR = incidence rate per 100 person-years
a Difficulty in affording house-related expenses was defined as a participant’s self-reported “Very difficult” or “Fairly difficult” for the following question:
“Considering your household income, how difficult is it for you to meet your monthly housing-related costs?(Housing costs include rent/mortgage, property
taxes and utilities only).”
b A 5-point Likert scale (strongly agree to strongly disagree) was used. We dichotomized their response into “yes” (strongly agree/agree) and “no” (neutral/
disagree/strongly disagree).
c Addiction to alcohol was defined as whether HIV-positive participants had a diagnostic code of alcohol dependence/abuse in OHIP (ICD-9: 303) or in main
diagnosis of DAD and NACRS (ICD-9-CM: 303; ICD-10-CA: F10), from the earliest available records in these databases to a day before the baseline.
d History of depression was defined as having a past depression-related diagnosis identified in OHIP records (OHIP ICD-9: 296 and 311), from the earliest
available records to a year before the baseline.
e There are two instruments for identifying current depressive symptoms administered by clinic nurses and assistant during the participant’s regular clinical
appointments. Due to constraints on human resources and time in several HIV clinics, 61% of HIV-positive participants were administered with the 10-item
Kessler Psychological Distress Scale (K10) and 39% were administrated with the 20-item Centre for Epidemiologic Studies Depression Scale (CES-D20).
Full details of the cohort can be found on the study website: http://www.ohtncohortstudy.ca/
doi:10.1371/journal.pone.0165816.t003
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divorced/single or widowed, had completed high school or less, had annual household income
less than $20K, had non-suppressed recent viral loads, lived in poorer housing, and/or who
completed the K10.
Mental Disorder Co-Morbidities
HIV-positive participants with current depressive symptoms had more additional mental dis-
orders compared to their counterparts without these symptoms (3 v. 2, p-value< 0.001). Pro-
files of other mental disorders by participants’ baseline depressive symptoms status are
available in Table 4. In particular, depressed participants were likely to be diagnosedwith senile
dementia, alcohol psychosis, drug psychosis, schizophrenia, other psychosis, anxiety, personal-
ity disorders, alcoholism, drug dependence, tobacco abuse, psychosomatic disturbance, habit
spasms, or adjustment reaction.We noted that a high prevalence (78–92%) of anxiety-related
diagnosis (ICD-9: 300) among both depressed and non-depressed HIV-positive participants.
This might be due to the fact that this diagnostic code is often used by Ontario physicians for a
range of anxiety-related symptoms among Ontario population; therefore, the codemight over-
estimate the prevalence of anxiety-related conditions.
Factors Associated with Point Prevalence, Recurrence and Incidence of
Current Depressive Symptoms
The results of our multivariable analyses for associations between factors and point prevalence,
first recurrence and incidence of current depressive symptoms are presented in Tables 5 to 7.
Table 4. History of Mental Disorders Diagnosis by Current Depressive Symptoms Status at Baseline (N = 3,816).
ICD-9 Mental Disorders Sub-chapters a ICD-9 b Current Depressive
symptoms
p-value
With Without
(N = 1070) (N = 2746)
Median number of mental disorders diagnosis, (Interquartile range [IQR]) 3 (2–4) 2 (1–3) < 0.0001
Senile dementia, presenile dementia 290 6.0% 3.8% 0.002483
Alcoholic psychosis, delirium tremens, Korsakov’s psychosis 291 2.6% 0.9% < 0.0001
Drug psychosis 292 0.9% 2.2% 0.0006531
Schizophrenia 295 8.9% 4.1% < 0.0001
Paranoid states 297 1.5% 1.1% 0.2589
Other psychoses 298 9.1% 4.2% < 0.0001
Anxiety neurosis, hysteria, neurasthenia, obsessive compulsive neurosis, reactive depression 300 91.6% 78.4% < 0.0001
Personality disorders 301 18.0% 7.8% < 0.0001
Sexual deviations 302 3.5% 3.0% 0.4514
Alcoholism 303 19.6% 10.1% < 0.0001
Drug dependence, drug addiction 304 34.7% 19.5% < 0.0001
Tobacco abuse 305 13.1% 10.2% 0.01156
Psychosomatic disturbances 306 16.3% 13.5% 0.03145
Habit spasms, tics, stuttering, tension headaches, anorexia nervosa, sleep disorders, enuresis 307 37.0% 26.3% <0.0001
Adjustment reaction 309 25.5% 17.6% < 0.0001
Behaviour disorders of childhood and Adolescence 313 3.4% 2.2% 0.04388
Hyperkinetic syndrome of childhood 314 2.1% 1.4% 0.09025
a Mental disorders sub-chapters were defined according to ICD-9 diagnostics codes in the resource manual for physicians
b A modified and abbreviate 3-digit version of the ICD-9 diagnostic codes were adopted for physical billings in the OHIP database.
doi:10.1371/journal.pone.0165816.t004
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For point prevalence, we found that depressed participants were more likely to be younger,
female and have a history of depression. They were also more likely to have difficulty in afford-
ing housing-related expenses, have a history of depression, feel worried about their housing sit-
uation, receive government disability subsidies, be unemployed, use recreational drugs, and
have completed the K10 instrument (Table 5). Participants protected from prevalent depressive
symptoms were more likely to have better control of their housing situation, more likely to like
their neighbourhoodand more likely to have better physical health (Table 5).
For first recurrence, our multivariable model was stratified by instrument type and recrea-
tional drug use because these variables did not meet the proportionality assumptions. Partici-
pants with greater risk of first recurrent depressive symptoms were more likely to feel worried
about their housing situation (Table 6). We noted that participants with a history of depression
were more likely to have recurrent depressive symptoms at a borderline statistically significant
level (p-value = 0.082) (Table 6). Participants with better physical health or non-suppressed
viral loads were less likely to have recurrent depressive symptoms (Table 6).
For incidence, our multivariable model was stratified by general health quality-of-life
because this variable did not meet the proportionality assumptions. We found that participants
at risk of developing current depressive symptoms were likely to be younger, gay or bisexual,
unable to afford housing-related expenses, feel worried about eviction, or use recreational drug
(Table 7). Participants with better physical health who liked their neighbourhoodsand were,
married or living with partners were less likely to have incident depressive symptoms
(Table 7).
Discussion
To our knowledge, this is the first study describing the prevalence, recurrence and incidence of
current depressive symptoms systematically and longitudinally among people living with HIV
receiving care in Ontario, Canada.We found that the prevalence, recurrence, and incidence of
current depressive symptoms in HIV-positive participants are high. Approximately 28% of
HIV-positive participants were identifiedwith current depressive symptoms, and the cumula-
tive incidence was approximately 14%. Our results also revealed that depressive symptoms in
HIV-positive participants was likely to be chronic and recurrent. Of those with a prevalent case
at baseline, 43% had a recurrent depressive episode during our five-year follow-up period. Ele-
vated point prevalent and rates of recurrent or incident depressive symptoms were statistically
significant among individuals with a history of depression and among those who were: female;
younger; lesbian, gay, or bisexual; living in poorer housing conditions; recreational drug users;
unemployed; or receiving government disability subsidies.
In Ontario, Canada, our study is the first to provide comprehensive evidence of the burden
of depression and the underlying catalysts of the condition from a longitudinal perspective.
This is an important first step to inform health care providers, policy-makers, and program
planners whenmaking decisions and planning for evidence-basedmental health care and sup-
port for people living with HIV in Ontario. In North America, although in past decades, efforts
were made to coordinate and integrate mental health care and support in HIV care, unmet
needs in mental health care and services still remain a major challenge for these individuals—
half of people living with HIV are under-recognized for their depressive symptoms condition,
and only half are being treated [6–9,67,68]. Several studies have revealed that mental health
care in the current HIVmodel is not well-coordinated and integrated [69–71]. A recent U.S.
study showed that depression is not regularly monitored in people living with HIV despite the
high prevalence of depression in this population—only 31% of 72 HIV care providers from
large academicmedical centres routinely assess depression for people living with HIV, and
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Table 5. Adjusted Relative Risk (aRR) with 95% Confidence Intervals (CI) for the Explanatory Variables of Point Prevalence of Current Depressive
Symptoms among HIV-positive Participants (N = 3,816).
Explanatory Variables Full Model Final Model
aRR 95% CI aRR 95% CI
Demographics
Age
16–29 years 1.35 (1.04, 1.75) 1.36 (1.06, 1.76)
30–39 years 1.35 (1.13, 1.61) 1.36 (1.14, 1.63)
40–49 years 1.23 (1.07, 1.42) 1.25 (1.09, 1.44)
 50 years (reference) 1
Gender
Female 1.22 (1.07, 1.66) 1.20 (1.02, 1.40)
Male (reference) 1 1
Sexual orientation
Gay, lesbian, or bisexual 1.01 (0.87, 1.16) 0.99 (0.86, 1.14)
Heterosexual (reference) 1 1
Marital status
Married / living with partners 0.89 (0.78, 1.02) 0.88 (0.77, 1.00)
Single, separated/divorced, or widowed (reference) 1 1
Ethnic identity
First Nation, Metis, or Inuit 1.02 (0.86, 1.21) 1.04 (0.87, 1.23)
African, Caribbean, Asian, or Latin American 1.26 (0.99, 1.60) 1.25 (0.99, 1.59)
European descent (reference) 1 1
Immigration status
Canadian immigrant 1.13 (0.99, 1.30) 1.11 (0.97, 1.27)
Canadian born (reference) 1 1
Socio-economic Status
Current employment status
Unemployed 1.33 (1.07, 1.66) 1.32 (1.07, 1.64)
Student/Retired 0.85 (0.62, 1.17) 0.83 (0.61, 1.14)
Recipient of Ontario Disability Support Program 1.43 (1.20, 1.70) 1.42 (1.20, 1.69)
Employed (reference) 1 1
Education attainment
Completed high school or less 1.01 (0.90, 1.14) — —
More than high school (reference) 1
Annual household income (CAD) before withholding taxes/benefits
< $20,000 1.00 (0.82, 1.22) 1.03 (0.85, 1.25)
$20,000 to $39,999 1.06 (0.87, 1.28) 1.08 (0.89, 1.30)
$40,000 to $49,999 0.93 (0.74, 1.17) 0.97 (0.77, 1.21)
 $50,000 (reference) 1 1
Housing and Neighbourhood Conditions
Difficulty in affording housing-related expenses a
Yes 1.21 (1.07, 1.38) 1.21 (1.07, 1.37)
No (reference) 1 1
Worry about being force out from their home b
Yes 1.32 (1.17, 1.50) 1.31 (1.16, 1.48)
No (reference) 1 1
Having control over their housing situation b
Yes 0.83 (0.73, 0.95) 0.84 (0.73, 0.95)
No (reference) 1 1
Sense of belonging to neighbourhood b
Yes 0.89 (0.79, 1.02) 0.89 (0.79, 1.02)
No (reference) 1 1
Perceive good location of their home b
(Continued)
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Table 5. (Continued)
Explanatory Variables Full Model Final Model
aRR 95% CI aRR 95% CI
Yes 0.84 (0.73, 0.95) 0.83 (0.73, 0.96)
No (reference) 1 1
Harmful Behaviours
Recreational drug use in past 6 months
Yes 1.21 (1.06, 1.37) 1.21 (1.07, 1.38)
No (reference) 1 1
Prior diagnosis of alcohol abuse c
Yes 1.03 (0.89, 1.20) — —
No (reference) 1
Current smoker
Yes 1.10 (0.97, 1.25) — —
No (reference) 1
Health Status
History of depression d
Yes 1.48 (1.31, 1.67) 1.50 (1.33, 1.69)
No (reference) 1 1
Physical component of SF-12 (Increased by every five points)
Physical functioning 1.00 (0.96, 1.03) — —
Bodily pain 0.97 (0.94, 0.99) 0.97 (0.94, 0.99)
Role functioning 0.89 (0.86, 0.93) 0.89 (0.87, 0.93)
General health 0.91 (0.89, 0.94) 0.91 (0.89, 0.93)
Charlson co-morbidity index  1
Yes 0.91 (0.80, 1.02) — —
No (reference) 1
Non-suppressed recent viral loads (> 50 μL) (in past 6 months)
Yes 1.07 (0.940, 1.21) 1.07 (0.95, 1.21)
No (reference) 1 1
Years since HIV diagnosis (Increased by a year) 1.00 (0.99, 1.01) 1.00 (0.99, 1.01)
Instrument type e
K10 1.30 (1.17, 1.48) 1.32 (1.17, 1.49)
CES-D20 (reference) 1 1
Footnotes: This table contains the full model (with all explanatory variables) and the final set of explanatory variables retained in the multivariable modified
Poisson regression models with sandwich variance estimators for point prevalence of current depressive symptoms.
a Difficulty in affording house-related expenses was defined as a participant’s self-reported “Very difficult” or “Fairly difficult” for the following question:
“Considering your household income, how difficult is it for you to meet your monthly housing-related costs?(Housing costs include rent/mortgage, property
taxes and utilities only).”
b A 5-point Likert scale (strongly agree to strongly disagree) was used. We dichotomized their response into “yes” (strongly agree/agree) and “no” (neutral/
disagree/strongly disagree).
c Addiction to alcohol was defined as whether HIV-positive participants had a diagnostic code of alcohol dependence/abuse in OHIP (ICD-9: 303) or in main
diagnosis of DAD and NACRS (ICD-9-CM: 303; ICD-10-CA: F10), from the earliest available records in these databases to a day before the baseline.
d History of depression was defined as having a past depression-related diagnosis identified in OHIP records (OHIP ICD-9: 296 and 311), from the earliest
available records to a year before the baseline.
e There are two instruments for identifying current depressive symptoms administered by clinic nurses and assistant during the participant’s regular clinical
appointments. Due to constraints on human resources and time in several HIV clinics, 61% of HIV-positive participants were administered with the 10-item
Kessler Psychological Distress Scale (K10) and 39% were administrated with the 20-item Centre for Epidemiologic Studies Depression Scale (CES-D20).
Full details of the cohort can be found on the study website: http://www.ohtncohortstudy.ca/
doi:10.1371/journal.pone.0165816.t005
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Table 6. Adjusted Hazard Ratio (aHR) with 95% Confidence Intervals (CI) for Explanatory Variables of the First Recurrence of Current Depressive
Symptoms among HIV-positive Participants (N = 957).
Explanatory Variables Full Model Final Model
aHR 95% CI aHR 95% CI
Demographics
Age
16–29 years 0.96 (0.47, 1.96) 1.05 (0.56, 1.95)
30–39 years 0.99 (0.66, 1.49) 0.98 (0.68, 1.41)
40–49 years 1.18 (0.90, 1.54) 1.26 (0.98, 1.61)
 50 years (reference) 1
Gender
Female 0.98 (0.67, 1.43) 0.98 (0.73, 1.30)
Male (reference) 1 1
Sexual orientation
Gay, lesbian, or bisexual 0.98 (0.71, 1.38) — —
Heterosexual (reference) 1
Marital status
Married / living with partners 1.00 (0.77, 1.32) — —
Single, separated/divorced, or widowed (reference) 1
Ethnic identity
First Nation, Metis, or Inuit 0.86 (0.59, 1.26) — —
African, Caribbean, Asian, or Latin American 0.55 (0.25, 1.23) — —
European descent (reference) 1
Immigration status
Canadian immigrant 1.25 (0.94, 1.66) 1.29 (1.00, 1.66)
Canadian born (reference) 1 1
Socio-economic Status
Current employment status
Unemployed 0.96 (0.57, 1.62) — —
Student/Retired 1.17 (0.68, 2.01) — —
Recipient of Ontario Disability Support Program 0.91 (0.68, 1.21) — —
Employed (reference) 1
Education attainment
Completed high school or less 1.07 (0.82, 1.39) — —
More than high school (reference) 1
Annual household income (CAD) before withholding taxes/benefits
< $20,000 1.02 (0.69, 1.50) 0.99 (0.72, 1.36)
$20,000 to $39,999 0.96 (0.65, 1.41) 0.94 (0.67, 1.33)
$40,000 to $49,999 0.73 (0.45, 1.17) 0.72 (0.46, 1.12)
 $50,000 (reference) 1 1
Housing and Neighbourhood Conditions
Difficulty in affording housing-related expenses a
Yes 1.13 (0.87, 1.45) — —
No (reference) 1
Worry about being force out from their home b
Yes 1.37 (1.05, 1.78) 1.49 (1.17, 1.90)
No (reference) 1 1
Having control over their housing situation b
Yes 0.85 (0.65, 1.12) — —
No (reference) 1
Sense of belonging to neighbourhoods b
Yes — — — —
No (reference)
Perceive good location of their home b
Yes 1.00 (0.74, 1.37) — —
No (reference) 1
Harmful Behaviours
Recreational drug use in past 6 months
Yes — — — —
(Continued)
Epidemiology of Current Depressive Symptoms among People Living with HIV
PLOS ONE | DOI:10.1371/journal.pone.0165816 November 1, 2016 18 / 29
Table 6. (Continued)
Explanatory Variables Full Model Final Model
aHR 95% CI aHR 95% CI
No (reference)
Prior diagnosis of alcohol abuse c
Yes 0.91 (0.65, 1.28) — —
No (reference) 1
Current smokers
Yes 1.05 (0.82, 1.35) — —
No (reference) 1
Health Status
History of depression d
Yes 1.23 (0.96, 1.57) 1.23 (0.97, 1.54)
No (reference) 1 1
Use of antidepressant (in past 12 months) e
Yes 1.13 (0.84, 1.51) 1.09 (0.82, 1.44)
No (reference) 1 1
Physical component of SF-12 (Increased by every five points)
Physical functioning 0.95 (0.89, 1.02) 0.95 (0.89, 1.02)
Bodily pain 1.04 (0.99, 1.10) 1.04 (0.98, 1.09)
Role functioning 0.88 (0.81, 0.95) 0.88 (0.82, 0.95)
General health 0.94 (0.89, 0.99) 0.94 (0.89, 0.99)
Charlson co-morbidity index 1
Yes 1.01 (0.77, 1.30) — —
No (reference) 1
Non-suppressed recent viral loads (> 50 μL) (in past 6 months)
Yes 1.01 (0.78, 1.31) — —
No (reference) 1
Years since HIV diagnosis (Increased by every year) 0.99 (0.98, 1.01) — —
Instrument type f
K10 2.24 (1.66, 3.03) — —
CES-D20 (reference) 1
This table contains the full model (with all explanatory variables) and the final set of explanatory variables retained in the multivariable Cox proportional
hazard regression models for the first recurrence of current depressive symptoms. The full Cox proportional hazard model was stratified by sense of
belonging to their neighbourhoods and recreational drug use because these variables did not satisfy proportionality assumption. The final Cox proportional
hazard model was stratified by instrument type and recreational drug use because these variables did not satisfy proportionality assumption.
a Difficulty in affording house-related expenses was defined as a participant’s self-reported “Very difficult” or “Fairly difficult” for the following question:
“Considering your household income, how difficult is it for you to meet your monthly housing-related costs?(Housing costs include rent/mortgage, property
taxes and utilities only).”
b A 5-point Likert scale (strongly agree to strongly disagree) was used. We dichotomized their response into “yes” (strongly agree/agree) and “no” (neutral/
disagree/strongly disagree).
c Addiction to alcohol was defined as whether HIV-positive participants had a diagnostic code of alcohol dependence/abuse in OHIP (ICD-9: 303) or in main
diagnosis of DAD and NACRS (ICD-9-CM: 303; ICD-10-CA: F10), from the earliest available records in these databases to a day before the baseline.
d History of depression was defined as having a past depression-related diagnosis identified in OHIP records (OHIP ICD-9: 296 and 311), from the earliest
available records to a year before the baseline.
e The definition of antidepressants was based on the first line of antidepressants for managing depression in adults recommended by the Canadian Network
for Mood and Anxiety Treatments (CANMAT) Clinical guidelines (Lam et al., 2009)
f There are two instruments for identifying current depressive symptoms administered by clinic nurses and assistant during the participant’s regular clinical
appointments. Due to constraints on human resources and time in several HIV clinics, 61% of HIV-positive participants were administered with the 10-item
Kessler Psychological Distress Scale (K10) and 39% were administrated with the 20-item Centre for Epidemiologic Studies Depression Scale (CES-D20).
Full details of the cohort can be found on the study website: http://www.ohtncohortstudy.ca/
doi:10.1371/journal.pone.0165816.t006
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Table 7. Adjusted Hazard Ratios (aHR) with 95% Confidence Intervals (CI) for the Explanatory Variables of Incidence of Current Depressive
Symptoms among HIV-positive Patients Participants (N = 1,745).
Explanatory Variables Full Model Final Model
aHR 95% CI aHR 95% CI
Demographics
Age
16–29 years 1.94 (0.97, 3.86) 2.34 (1.35, 4.04)
30–39 years 1.70 (1.06, 2.73) 1.96 (1.31, 2.93)
40–49 years 1.43 (0.99, 2.06) 1.56 (1.13, 2.16)
 50 years (reference) 1 1
Gender
Female 1.07 (0.62, 1.84) 1.32 (0.84, 2.09)
Male (reference) 1 1
Sexual orientation
Gay, lesbian, or bisexual 1.55 (0.98, 2.46) 1.49 (1.02, 2.19)
Heterosexual (reference) 1 1
Marital status
Married / living with partners 0.72 (0.52, 1.01) 0.69 (0.52, 0.91)
Single, separated/divorced, or widowed (reference) 1 1
Ethnic identity
First Nation, Metis, or Inuit 1.26 (0.76, 2.11) 1.24 (0.81, 1.92)
African, Caribbean, Asian, or Latin American 2.02 (0.75, 5.41) 2.06 (0.88, 4.82)
European descent (reference) 1 1
Immigration status
Canadian immigrant 1.03 (0.71, 1.50) — —
Canadian born (reference) 1
Socio-economic Status
Current employment status
Unemployed 1.33 (0.69, 2.59) — —
Student/Retired 0.77 (0.41, 1.46) — —
Recipient of Ontario Disability Support Program 1.11 (0.76, 1.63) — —
Employed (reference) 1
Educational attainment
Completed high school or less 1.13 (0.80, 1.60) — —
More than high school (reference) 1
Annual household income (CAD) before withholding taxes/benefits
< $20,000 1.39 (0.85, 2.26) — —
$20,000 to $39,999 1.1 (0.69, 1.75) — —
$40,000 to $49,999 1.37 (0.85, 2.20) — —
 $50,000 (reference) 1
Housing and Neighbourhood Conditions
Difficulty in affording housing-related expenses a
Yes 1.53 (1.07, 2.19) 1.60 (1.17, 2.18)
No (reference) 1
Worry about being force out from their home b
Yes 1.34 (0.90, 1.98) 1.64 (1.17, 2.28)
No (reference) 1
Having control over their housing situation b
Yes 0.72 (0.49, 1.07) — —
No (reference) 1
Sense of belonging to the neighbourhoods b
Yes 0.82 (0.57, 1.18) — —
No (reference) 1
Perceive good location of their home b
(Continued)
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Table 7. (Continued)
Explanatory Variables Full Model Final Model
aHR 95% CI aHR 95% CI
Yes — — 0.56 (0.40, 0.78)
No (reference) 1
Harmful Behaviours
Recreational drug use in past 6 months
Yes 1.74 (1.17, 2.58) 1.52 (1.07, 2.17)
No (reference) 1 1
Prior diagnosis of alcohol abuse c
Yes 0.8 (0.44, 1.47) — —
No (reference) 1
Current smoker
Yes 1.08 (0.78, 1.51) — —
No (reference) 1
Health Status
History of depression d
Yes 1.48 (1.31, 1.67) — —
No (reference) 1
Physical component of SF-12 (Increased by every five points)
Physical functioning 1 (0.90, 1.09) — —
Bodily pain 0.93 (0.87, 1.01) 0.93 (0.87, 0.99)
Role functioning 0.88 (0.80, 0.98) 0.88 (0.82, 0.95)
General health 0.78 (0.73, 0.84) — —
Charlson co-morbidity index  1
Yes 0.56 (0.38, 0.84) 0.71 (0.50, 0.99)
No (reference) 1
Non-suppressed recent viral loads (> 50 μL) (in past 6 months)
Yes 0.85 (0.57, 1.29) 1.04 (0.73, 1.47)
No (reference) 1 1
Years since HIV diagnosis (Increased by every year) 0.99 (0.97, 1.02) — —
Instrument type e
K10 1.31 (0.94, 1.83) 1.37 (1.02, 1.84)
CES-D20 (reference) 1 1
Footnotes: This table contains the full model (with all explanatory variables) and the final set of explanatory variables retained in the multivariable Cox
proportional hazard models for incidence of current depressive symptoms. The full Cox proportional hazard model was stratified by perception of good
location of participants’ home because this variable did not satisfy proportionality assumption. The final Cox proportional hazard model was stratified by
general health quality-of-life because this variable did not satisfy proportionality assumption.
a Difficulty in affording house-related expenses was defined as a participant’s self-reported “Very difficult” or “Fairly difficult” for the following question:
“Considering your household income, how difficult is it for you to meet your monthly housing-related costs?(Housing costs include rent/mortgage, property
taxes and utilities only).”
b A 5-point Likert scale (strongly agree to strongly disagree) was used. We dichotomized their response into “yes” (strongly agree/agree) and “no” (neutral/
disagree/strongly disagree).
c Addiction to alcohol was defined as whether HIV-positive participants had a diagnostic code of alcohol dependence/abuse in OHIP (ICD-9: 303) or in main
diagnosis of DAD and NACRS (ICD-9-CM: 303; ICD-10-CA: F10), from the earliest available records in these databases to a day before the baseline.
d History of depression was defined as having a past depression-related diagnosis identified in OHIP records (OHIP ICD-9: 296 and 311), from the earliest
available records to a year before the baseline.
e There are two instruments for identifying current depressive symptoms administered by clinic nurses and assistant during the participant’s regular clinical
appointments. Due to constraints on human resources and time in several HIV clinics, 61% of HIV-positive participants were administered with the 10-item
Kessler Psychological Distress Scale (K10) and 39% were administrated with the 20-item Centre for Epidemiologic Studies Depression Scale (CES-D20).
Full details of the cohort can be found on the study website: http://www.ohtncohortstudy.ca/
doi:10.1371/journal.pone.0165816.t007
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only 13% follow-up with their patients within 2 weeks after prescribing an antidepressant [69].
There are many challenges to delivering regular care for depression within current HIV care
model. Curran et al. (2011) conducted a qualitative study with eight people living with HIV,
sevenmental health providers, and 18 HIV health care providers at the U.S. Veterans Affairs
HIV clinics. The researchers revealed that there are time constraints in dealing with depression
along with other complex health conditions during appointments [70]. Some providers are
worried about drug interactions between combination antiretroviral therapy (cART) and anti-
depressants, and others had difficulty referring their patients to mental health specialists [70].
Some providers found it difficult to diagnose depression because of the similarity between
depressive symptoms and HIV symptoms; and others did not feel that they had the expertise
necessary to treat depression in these patients [70]. Our findings of the high point prevalence
and recurrence rate of depressive symptoms in people living with HIV reinforce the impor-
tance of effective delivery of mental health care in the context of HIV treatment and demon-
strate the need for long-term support and routine management of depression, particularly
among those at high risk.
When compared to prior studies, our results on the point prevalence of current depressive
symptoms (28%) are comparable to recent findings (23–26%) from large-scale studies con-
ducted in the U.S. [58,72,73]. However, our results showed a lower recurrence rate of 43%
when compared to the 61% rate found by Malee et al.(2014) [39] and to the 90% rate found by
an older study conducted by Johnson and colleagues (1999) [40]. This differencemight due to
the fact that Malee’s sample was restricted to HIV-positive females and Johnson’s sample was
restricted to injection drug users; these participants are more likely to develop depressive symp-
toms. Additionally, our definition of “recurrent depressive symptoms” used a two-year window
from baseline whileMalee et al used one-year window and Johnson et al. used a six-month
window. Furthermore, our study focused on current depressive symptoms alone while the
Malee study examined a number of psychiatric disorders.
Our cumulative incidence of depressive symptoms of 14% during follow-up among a
depressive symptoms-free cohort at baseline was lower than cumulative incidence of 21%
reported in the Malee study [39]. Our incidence rate of 4.5 per 100 person-years was similar to
the rate of 3.9 per 100 person-years reported by Anagnostopoulos et al. in a depressive symp-
toms -free sample of the Swiss HIV Cohort [38]. However, our incidence rate was higher than
prior findings of 1.04–2.2 per 100 person-years reported in French and French Guiana studies
[35–37] where their denominator included all participants and that would underestimate the
incidence rate.
Consistent with prior studies [38,58–61], we found an elevated point prevalence of depres-
sive symptoms among HIV-positive participants who had a history of depression and among
those who were: female, younger, recreational drug users, or unemployed/disabled. Unlike the
U.S. evidence [58,61], we did not note differences among ethnoculturalminorities. This might
due to 84% of our sample being Caucasian. Unlike prior studies [58,74], we did not find that
being lesbian, gay, or bisexual was associated with an elevated point prevalence of depressive
symptoms; however, we did find those who self-reported as lesbian, gay, or bisexual were about
two times more likely to develop incident depressive symptoms during follow-up.
Our study is the first to provide further examination on factors associated with recurrent
depressive symptoms in people living with HIV. AlthoughMalee et al. also explored factors
associated to recurrent depressive symptoms, this study was limited to specific factors related
to HIV-positive mothers (e.g. single parenting, functional limitations for being a caregiver,
smoking during pregnancy, etc.) [39]. Additionally, Malee et al. also did not consider history of
depression in their model [39]. Consistent with a systematic review focusing on the general
population [75], our results indicate that a history of depression was associated with recurrent
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depressive symptoms, although it was found at a borderline statistically significant level (p-
value = 0.082). The borderline level might due to the use of diagnostic codes in physicians’ bill-
ing records for identifying a history of depression, which might contribute to some degree of
misclassification [76].
With regard to factors associated with incidence rate of depressive symptoms, consistent
with prior evidence, we found HIV-positive participants who were younger or recreational
drug users were more likely to develop incident depressive symptoms [35–38]. Unlike prior
evidence [35,37], we did not find that those with more severe HIV conditions were more likely
to develop incident depressive symptoms but we did observe the incident cases were associated
with poor physical health. Additionally, we noted that the HIV-positive participants with other
physical comorbidities were less likely to develop incident depressive symptoms; however,
these participants might be sicker and might be more likely to die before the incident cases
occur [13].
Our study is the first to report associations between prevalent, recurrent and incident
depressive symptoms and an extensive number of housing and neighbourhood-relatedcontex-
tual factors in people living with HIV. Cross-sectional evidence has shown that poorer and
unstable housing conditions are strong explanatory variables of poormental health outcomes
among these people living with HIV [77,78]. Our study further explored causal relationship
between housing and neighbourhood-related factors and incidence and recurrence of depres-
sive symptoms. HIV-positive participants who felt worried about their housing situation were
more likely to have elevated recurrence rate. HIV-positive participants who had difficulty in
affording housing-related expenses, or who felt worried about their housing situation were
more likely to have higher rate of incident depressive symptoms whereas those who perceived
good location of their home were protected from developing incident depression. Our results
from a longitudinal perspective strengthen the current knowledge that poorer housing and
neighbourhoodconditions may worsen depressive symptoms in people living with HIV in the
long run. In North America, people living with HIV are strugglingwith poverty and unstable
housing situations [23,43]. These results also reinforce the importance of providing stable and
good quality neighbourhoodconditions in current HIV policy and programs, which may help
alleviate depressive symptoms and improve the overall well-being of people living with HIV
over time.
Our study has several strengths. First, the OCS is the largest HIV cohort in Ontario, repre-
senting about one-fifth of the HIV-positive population in the province; participant characteris-
tics generally represent typical HIV-positive individuals in care [43]. Second, this is the first
study to provide comprehensive information about depressive symptoms and its underlying
associated catalysts among people living with HIV from a longitudinal perspective. Third, our
use of linked data between the OCS (prospective cohort study) and administrative databases
overcomes limitations associated with using a single dataset. Fourth, the current study is one of
the first large-scale HIV cohort studies to demonstrate an association between housing and
neighbourhood factors and prevalent, recurrent, and incident depressive symptoms in Canada.
Our study has some limitations. First, we relied on screening instruments (i.e., the CES-D20
and K10), to identify current depressive symptoms, but excellent agreement between these
instruments and DSM-IV-TR criteria (for major depression diagnosis) have been demon-
strated in this cohort (Sensitivity: 0.97–1.0; Specificity: 0.81–0.87) [46]. The two instruments
also demonstrated good interrater agreement when compared against DSM-IV-TR criteria.
Second, although our data sources are comprehensive, some important explanatory variables—
including childhood adversity, stigma and coping strategies—were not included in our analysis.
Third, our recurrence and incidence rates might be underestimated because there were gaps
between our measures of depressive symptoms; similarly, the rates might be overestimated
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because participants were followed prospectively, possibly leaving the HIV-positive partici-
pants with more complex medical needs in the study. Fourth, we relied on depression-related
diagnostic codes from participants’ health service utilization records to identify an eight-week
depression-free periodwhen estimating recurrent depressive symptoms rate. However, health
service utilization records were dependent on whether the HIV-positive participants sought
help from physicians, frequency of their doctor appointments, or how well the participants can
access health services. Future research should verify our results of recurrent rate using more
accurate depressive symptoms measures. Additionally, misclassification is possible—a valida-
tion study showed that although depressive symptoms-related diagnostic codes have good pos-
itive (>89%) and negative (>91%) predictive values for identifying depressive symptoms,
sensitivity of these codes were low (28–35%) [76].
Conclusions
Despite these limitations, the linked data between the OCS and the administrative databases
offer useful new information in understanding the epidemiology of depressive symptoms in
HIV-positive participants from a longitudinal perspective—currentdepressive symptoms is
highly prevalent and is likely to recur over time, particularly in some high-risk subgroups. Our
results support the direction of Ontario’s HIV/AIDS Strategy to 2026, which addresses medical
concerns associated with HIV (such as depression) and the social drivers of health in order to
enhance the overall well-being of people living with or at risk of HIV. Our findings reinforce
the importance of providing effectivemental health care and demonstrate the need for long-
term support and routine management of depression, particularly for individuals at high risk.
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